Transdermal Drug Delivery Articles & Analysis
14 news found
CD Formulation, a leading force in biotechnology research and development, is at the forefront of revolutionizing transdermal delivery systems. As the demand for non-invasive, efficient drug delivery systems grows, CD Formulation has announced its abilities in providing a few transdermal delivery ...
In today’s evolving pharmaceutical landscape, the search for new drug delivery systems (DDS) is of paramount importance to improving therapeutic outcomes. ...
CD Formulation, a leading pharmaceutical contract service company, has recently unveiled groundbreaking hydrogel microneedle patch technology aiming at increase the drug loading capacity and enhance drug delivery efficiency. The new technology represents a significant advancement in the field of transdermal drug ...
This cutting-edge drug delivery system is poised to revolutionize medication administration, offering patients a more convenient and effective treatment method. ...
Transdermal drug delivery systems are very popular due to their benefits, such as improving bioavailability and reducing side effects. ...
With a relentless commitment to delivering innovative solutions and excellent customer service, CD Formulation has built a strong reputation in the industry, particularly in fields like Transdermal Patches Drug Delivery System, Oral Thin Films Drug Delivery, Microneedle Technology, Microsphere Development, etc. ...
One of the key areas of focus for CD Formulation is its Novel Drug Delivery System (NDDS) services. With a dedicated team of experts, the company offers an array of services aimed at designing and optimizing drug delivery systems. ...
CD Formulation, a reputable contract research organization (CRO) based in New York, has become a trusted partner for many pharmaceutical companies around the world seeking innovative drug formulation methods and solutions. Recently, CD Formulation further strengthened its role as a drug delivery expert by demonstrating its expertise in the ...
“Our new collection of pharmaceutical excipients covers a wide range of dosage forms, including liquids, solids, semi-solids, controlled-release, transdermal, mucosal, and micro drug delivery systems. Each formulation is meticulously designed to meet the unique needs of different medications and patient populations,” said the ...
The newly introduced solutions are focused on long-acting controlled-release microspheres and phase-transition microneedle patches, to meet the growing demand for novel biopharmaceuticals and biosimilars, while at the same time, improving efficacy, safety, and convenience in drug delivery. Microsphere and microneedle technologies have been gaining increasing ...
Choosing the most appropriate delivery system has tremendous benefits, including but not limited to controlled release of drugs, enhanced drug targeting, improved solubility and bioavailability of drugs. In the past decade, several new drug delivery systems have been formulated, in the hope to ...
Pilot, Randomized, Double-Blinded, Placebo Controlled Efficacy and Safety Study of a Transdermal Alkalinizing and Pain Relieving Treatment for Acute Gout Pain Objectives: Gout is characterized by a build-up of monosodium urate (MSU) crystals in and around the joints. ...
He has been a valued leader at large companies (3M) and emerging startups (Rion, StemoniX, Rebiotix) where he made significant contributions to the pioneering development of regenerative exosome and microbiome therapeutics, 3D organoids for drug discovery, and novel drug delivery technologies. Notably, Dr. Gordon led business and market ...
Dyve Biosciences received FDA clearance to begin a Phase 2 study of its DYV-700 transdermal therapeutic for the treatment of acute gout pain. Thousand Oaks, Calif.-based Dyve said it plans to begin the Targets study in the first quarter of 2020. It is slated to be a double-blind, placebo-controlled, randomized clinical trial to evaluate the efficacy of DYV-700 in patients with acute gout flare. ...